Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | GPR3 | P46089 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.39 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4236344 | 0.80 | SMN1; SMN2 (0.47) | SMN1; SMN2GPR3ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL6470929 | 0.78 | SMN1; SMN2 (0.41) | SMN1; SMN2GPR3ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL17394563 | 0.78 | GPR3 (0.50) | SMN1; SMN2GPR3CYP1A2CYP2C19ALDH1A1 | |
| SCHEMBL5733921 | 0.77 | ALDH1A1 (0.46) | SMN1; SMN2GPR3CYP1A2CYP2C19ALDH1A1 | |
| SCHEMBL29056986 | 0.74 | SMN1; SMN2 (0.50) | SMN1; SMN2CYP1A2CYP2C19ALDH1A1KDM4E | |
| SCHEMBL10901769 | 0.74 | SMN1; SMN2 (0.51) | SMN1; SMN2CYP1A2ALDH1A1KDM4EMEN1 | |
| SCHEMBL19583449 | 0.74 | GPR3 (0.46) | SMN1; SMN2GPR3CYP1A2CYP2C19ALDH1A1 | |
| SCHEMBL8076374 | 0.72 | KDM4E (0.57) | SMN1; SMN2CYP1A2CYP2C19ALDH1A1KDM4E | |
| SCHEMBL7255701 | 0.72 | MAPK1 (0.51) | SMN1; SMN2ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL9678983 | 0.72 | POLB (0.47) | SMN1; SMN2GPR3ALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2066648-B1 | SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS | ESTEVE LABOR DR (ES) | 2017-04-12 | — | — | EP | disclosed |
| US-9496507-B2 | Emitting compound and organic light emitting diode device using the same | LG DISPLAY CO., LTD. (KR) | 2016-11-15 | — | — | US | disclosed |
| CN-102803205-B | Alkali and free-radical generating agent, use its composition and solidify the method for described composition | THREE BOND CO.,LTD. (JP) | 2015-12-16 | — | — | CN | disclosed |
| CN-104977644-A | Polarization board and LCD panel | SUMITOMO CHEMICAL CO | 2015-10-14 | — | — | CN | disclosed |
| CN-104755525-A | Radiation-curable composition, adhesive, and polarizing plate | DAICEL CORP | 2015-07-01 | — | — | CN | disclosed |
| CN-104345370-A | Optical film | SUMITOMO CHEMICAL CO | 2015-02-11 | — | — | CN | disclosed |
| CN-104345368-A | ELLIPTICAL POLARIZATION PLATE | SUMITOMO CHEMICAL CO | 2015-02-11 | — | — | CN | disclosed |
| CN-104345374-A | Optical film | SUMITOMO CHEMICAL CO | 2015-02-11 | — | — | CN | disclosed |
| CN-104345372-A | Optical film | SUMITOMO CHEMICAL CO | 2015-02-11 | — | — | CN | disclosed |
| CN-104345369-A | Optical film | SUMITOMO CHEMICAL CO | 2015-02-11 | — | — | CN | disclosed |
| CN-1633487-A | Adhesive sheet, semiconductor device and method for manufacturing the same | HITACHI CHEMICAL CO LTD (JP) | 2005-06-29 | — | — | CN | disclosed |
| US-20040096397-A1 | Sulfonated diarylrhodamine dyes | APPLERA CORPORATION (US) | 2004-05-20 | — | — | US | disclosed |
| WO-2004037805-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-05-06 | — | — | WO | disclosed |
| EP-1408090-A1 | Dibenzorhodamine dyes useful as fluorescent labelling agents | Applera Corporation (US) | 2004-04-14 | — | — | EP | disclosed |
| EP-1339798-A2 | SULFONATED DIARYLRHODAMINE DYES | Applera Corporation (US) | 2003-09-03 | — | — | EP | disclosed |
| US-6583168-B1 | Fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides in nucleic acid analysis | APPLERA CORPORATION | 2003-06-24 | — | — | US | disclosed |
| WO-2002044416-A2 | SULFONATED DIARYLRHODAMINE DYES AS FLUORESCENT LABELS | APPLERA CORPORATION (US) | 2002-06-06 | — | — | WO | disclosed |
| EP-1034221-A1 | DIBENZORHODAMINE DYES USEFUL AS FLUORESCENT LABELLING AGENTS | THE PERKIN-ELMER CORPORATION (US) | 2000-09-13 | — | — | EP | disclosed |
| US-6051719-A | FLUORESCENT LABELING REAGENTS | THE PERKIN-ELMER CORPORATION (US) | 2000-04-18 | — | — | US | disclosed |
| WO-1999027020-A1 | DIBENZORHODAMINE DYES USEFUL AS FLOURESCENT LABELLING AGENTS | THE PERKIN-ELMER CORPORATION (US) | 1999-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040096397-A1 | Sulfonated diarylrhodamine dyes | POLL, DUT, DPYD | SMN1; SMN2 1526/4885GPR3 2364/4885CYP1A2 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.